Skip to main content
Premium Trial:

Request an Annual Quote

Revvity Pin-Point Base Editing Platform Reagents

Revvity has launched its Pin-Point base editing platform reagents for advanced gene editing in preclinical laboratories. The initial reagent launch includes mRNAs for nCas9 and rat APOBEC and three guide RNAs designed to knock out TRAC, CD52, and PDCD1 loci. Revvity said it has performed extensive validation and demonstrated the reagents' performance in T cells and induced pluripotent stem cells.